Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Debt Ratio: 2020

  • Foghorn Therapeutics' Debt Ratio was N/A to 0.08 in Q4 2020 from the same period last year, while for Dec 2020 it was 0.08, marking a year-over-year change of. This contributed to the annual value of 0.08 for FY2020, which is N/A change from last year.
  • Foghorn Therapeutics' Debt Ratio amounted to 0.08 in Q4 2020, which was down 25.95% from 0.10 recorded in Q3 2020.
  • Over the past 5 years, Foghorn Therapeutics' Debt Ratio peaked at 0.10 during Q3 2020, and registered a low of 0.08 during Q4 2020.
  • For the 1-year period, Foghorn Therapeutics' Debt Ratio averaged around 0.09, with its median value being 0.09 (2020).